Clinical Trial Update: Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of hepatic artery infusion with floxuridine for pancreatic adenocarcinoma with liver metastases; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Pancreatic Adenocarcinoma

Drugs mentioned

• Floxuridine (FUDR) (floxuridine)

Snippet

Sponsor: Corewell Health West | Conditions: Pancreatic Adenocarcinoma, Liver Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING